欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号FR/V/0297/001
药品名称CANIGEN DHPPi
活性成分
    • canine adenovirus 0.0 CCID50
    • canine distemper virus 0.0 CCID50
    • canine parainfluenza virus 0.0 CCID50
    • canine parvovirus 0.0 CCID50
剂型Lyophilisate and Solvent
上市许可持有人VIRBAC
参考成员国 - 产品名称France (FR)
CANIGEN DHPPi
互认成员国 - 产品名称
    • Cyprus (CY)
    • Croatia (HR)
    • Slovenia (SI)
    • Slovakia (SK)
    • Romania (RO)
    • Czechia (CZ)
      CANIGEN DHPPi lyofilizát a rozpouštědlo pro injekční suspenzi pro psy
    • Bulgaria (BG)
    • Hungary (HU)
    • Estonia (EE)
      Canigen DHPPi
    • Lithuania (LT)
    • Latvia (LV)
      Canigen DHPPi liofilizāts un šķīdinātājs suspensijas injekcijām pagatavošanai suņiem
    • Poland (PL)
    • Finland (FI)
    • Norway (NO)
    • Sweden (SE)
    • Greece (GR)
    • Italy (IT)
    • Portugal (PT)
    • Spain (ES)
      CANIGEN DHPPi
    • Austria (AT)
      Virbagen canis SHAPPi Lyophilisat und Lösungsmittel zur Herstellung einer Injektionssuspension für H
    • Ireland (IE)
      CANIGEN DHPPi
    • United Kingdom (Northern Ireland) (XI)
      Canixin DHPPi
    • Luxembourg (LU)
    • Netherlands (NL)
    • Belgium (BE)
      Canigen DHPPi
    • Denmark (DK)
    • Germany (DE)
      Virbagen canis SHAPPi
许可日期2016/05/25
最近更新日期2023/10/09
药物ATC编码
    • QI07AD04 canine distemper virus + canine adenovirus + canine parvovirus + canine parainfluenza virus
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：Full dossier - art 12.3 Dir 2001/82/EC
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase